LUCENTIS Side Effects

7023601-3 | Myocardial Infarction
on Sep 30, 2010 Female patient from UNITED STATES , 89 years of age, weighting 165.0 lb, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Lucentis dosage: 0.05ml Once Intraocular. During the same period patient was treated with CHLORPROPAMIDE (View Chlorpropamide Review and Chlorpropamide Label ), TRIAMTERENE AND HYDROCHLOROTHIAZIDE (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ), FOLAMIN (View Folamin Review and Folamin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PRAVASTAIN (View Pravastain Review and Pravastain Label ).

7022668-6 | Retinal Ischaemia, Visual Acuity Reduced
Patient was taking Lucentis (View Usage). Patient had the following side effects: retinal ischaemia, visual acuity reduced on Sep 15, 2010 from SWITZERLAND Additional patient health information: Male patient , 85 years of age, . Lucentis dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), DIPYRIDAMOL (View Dipyridamol Review and Dipyridamol Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

7021222-X |
Adverse event was reported on Sep 15, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: Unk) . Location: SWITZERLAND , 73 years of age, .

7021184-5 | Myalgia
on Sep 14, 2010 Female patient from SWITZERLAND , weighting 143.3 lb, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: myalgia. Lucentis dosage: Unk. During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), PLAVIX (View Plavix Review and Plavix Label ), TAHOR (View Tahor Review and Tahor Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ERCEFURYL (View Ercefuryl Review and Ercefuryl Label ).


7013906-4 | Polypoidal Choroidal Vasculopathy
on Sep 09, 2010 Female patient from SWITZERLAND , 75 years of age, was treated with Lucentis (View Usage). Patient had the following side effects: polypoidal choroidal vasculopathy. Lucentis dosage: .

7013901-5 | Polypoidal Choroidal Vasculopathy
Patient was taking Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: polypoidal choroidal vasculopathy on Sep 09, 2010 from SWITZERLAND Additional patient health information: Female patient , 79 years of age, . Lucentis dosage: .

7013898-8 | Cerebrovascular Accident
Adverse event was reported on Sep 10, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: 0.5 Mg, Single) . Location: SWITZERLAND , 84 years of age, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), IRON (View Iron Review and Iron Label ), LOFEPRAMINE (View Lofepramine Review and Lofepramine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

7013895-2 | Polypoidal Choroidal Vasculopathy
on Sep 09, 2010 Male patient from SWITZERLAND , 77 years of age, was treated with Lucentis (View Usage). Patient had the following side effects: polypoidal choroidal vasculopathy. Lucentis dosage: .

7013893-9 | Polypoidal Choroidal Vasculopathy
on Sep 09, 2010 Male patient from SWITZERLAND , 64 years of age, was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: polypoidal choroidal vasculopathy. Lucentis dosage: .

7013807-1 | Polypoidal Choroidal Vasculopathy
Patient was taking Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: polypoidal choroidal vasculopathy on Sep 09, 2010 from SWITZERLAND Additional patient health information: Female patient , 65 years of age, . Lucentis dosage: .

7013805-8 | Polypoidal Choroidal Vasculopathy
Adverse event was reported on Sep 09, 2010 by a Male patient taking Lucentis (View Usage) (Dosage: ) . Location: SWITZERLAND , 81 years of age, Patient had the following side effects: polypoidal choroidal vasculopathy.

7013804-6 | Myocardial Infarction
on Sep 09, 2010 Female patient from SWITZERLAND , 95 years of age, was diagnosed with choroidal neovascularisation and was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: myocardial infarction. Lucentis dosage: .

7013798-3 | Polypoidal Choroidal Vasculopathy
on Sep 09, 2010 Female patient from SWITZERLAND , 75 years of age, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: polypoidal choroidal vasculopathy. Lucentis dosage: .

7012273-X | Myocardial Infarction
Patient was taking Lucentis (View Usage). Patient had the following side effects: myocardial infarction on Sep 22, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 185.0 lb, was diagnosed with diabetic retinal oedema and. Lucentis dosage: Masked, Monthly Intravitreal. During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ).

7008621-7 | Retinal Haemorrhage, Retinal Tear
Adverse event was reported on Sep 08, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: 0.05 Ml, Unk) was diagnosed with myopia and. Location: SWITZERLAND , 43 years of age, After Lucentis was administered, patient had the following side effects: retinal haemorrhage, retinal tear. During the same period patient was treated with LEVOFLOXACIN (Unk) (View Levofloxacin Review and Levofloxacin Label ).

7008465-6 | Subretinal Fibrosis
on Sep 08, 2010 Male patient from SWITZERLAND , 82 years of age, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: subretinal fibrosis. Lucentis dosage: .

7008006-3 | Agitation, Cerebrovascular Accident
on Sep 07, 2010 Female patient from BELGIUM , 79 years of age, was treated with Lucentis (View Usage). Patient had the following side effects: agitation, cerebrovascular accident. Lucentis dosage: Unk. During the same period patient was treated with TENORMIN (View Tenormin Review and Tenormin Label ), MACUGEN (Unk) (View Macugen Review and Macugen Label ). Patient was hospitalized.

7007516-2 | Vascular Graft Occlusion
Patient was taking Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: vascular graft occlusion on Sep 07, 2010 from SWITZERLAND Additional patient health information: Male patient , 68 years of age, . Lucentis dosage: 500 A?g, 1/month. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ).

7006409-4 | Retinal Haemorrhage
Adverse event was reported on Sep 07, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: ) . Location: SWITZERLAND , 73 years of age, Patient experienced the following unwanted or unexpected effects: retinal haemorrhage.

7003335-1 | Cerebrovascular Accident
on Sep 06, 2010 Male patient from SWITZERLAND , 78 years of age, was treated with Lucentis (View Usage). Patient had the following side effects: cerebrovascular accident. Lucentis dosage: Unk.

6992991-X |
on Sep 03, 2010 Male patient from SWITZERLAND , 78 years of age, was treated with Lucentis (View Usage). . Lucentis dosage: .

6992668-0 | Cerebrovascular Accident, Transient Ischaemic Attack
Patient was taking Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, transient ischaemic attack on Sep 03, 2010 from SWITZERLAND Additional patient health information: Female patient , 65 years of age, . Lucentis dosage: Unk. During the same period patient was treated with PHACOEMULSIFICATION OF RIGHT LENS (View Phacoemulsification Of Right Lens Review and Phacoemulsification Of Right Lens Label ).

6981010-7 | Aortic Stenosis, Coronary Artery Disease, Myocardial Infarction
Adverse event was reported on Sep 01, 2010 by a Male patient taking Lucentis (View Usage) (Dosage: ) . Location: SWITZERLAND , 91 years of age, Patient had the following side effects: aortic stenosis, coronary artery disease (What is coronary artery disease?), myocardial infarction. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FRUMIL (View Frumil Review and Frumil Label ). Patient was hospitalized.

6974252-8 | Cataract Operation
on Aug 26, 2010 Female patient from SWITZERLAND , 76 years of age, was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: cataract operation. Lucentis dosage: Unk.

6974250-4 | Optic Ischaemic Neuropathy
on Aug 27, 2010 Female patient from SWITZERLAND , 72 years of age, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: optic ischaemic neuropathy. Lucentis dosage: Unk.

6966319-5 | Cerebral Infarction
Patient was taking Lucentis (View Usage). Patient had the following side effects: cerebral infarction on Aug 23, 2010 from SWITZERLAND Additional patient health information: Male patient , 72 years of age, . Lucentis dosage: 0.05 Ml, Unk. During the same period patient was treated with VISUDYNE (Unk) (View Visudyne Review and Visudyne Label ).

6965573-3 | Acute Myocardial Infarction, Atrial Fibrillation
Adverse event was reported on Aug 27, 2010 by a Male patient taking Lucentis (View Usage) (Dosage: ) . Location: UNITED STATES , 81 years of age, weighting 190.0 lb, After Lucentis was administered, patient had the following side effects: acute myocardial infarction, atrial fibrillation (What is atrial fibrillation?). During the same period patient was treated with PULMICORT (View Pulmicort Review and Pulmicort Label ), VIGAMOX (Unk Gtt, Unk) (View Vigamox Review and Vigamox Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

6960893-0 | Visual Acuity Reduced
on Aug 20, 2010 Male patient from SWITZERLAND , 69 years of age, was diagnosed with retinal vein occlusion and was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: visual acuity reduced. Lucentis dosage: .

6956750-6 | Dizziness, Retinal Haemorrhage, Retinal Scar
on Aug 17, 2010 Male patient from SWITZERLAND , weighting 152.1 lb, was treated with Lucentis (View Usage). Patient had the following side effects: dizziness (What is dizziness?), retinal haemorrhage, retinal scar. Lucentis dosage: 0.05 Ml, Unk. During the same period patient was treated with GATIFLOXACIN (Unk) (View Gatifloxacin Review and Gatifloxacin Label ).

6945848-4 | Visual Impairment
Patient was taking Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: visual impairment on Aug 13, 2010 from SWITZERLAND Additional patient health information: Female patient , weighting 136.7 lb, . Lucentis dosage: 10 Mg/ml, Unk.

6945821-6 | Abdominal Pain, Eye Disorder, Herpes Zoster, Hyponatraemia, Nausea, Renal Infarct, Thrombosis
Adverse event was reported on Aug 23, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: Unk) . Location: UNITED STATES , weighting 100.3 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), eye disorder, herpes zoster, hyponatraemia, nausea (What is nausea?), renal infarct, thrombosis. During the same period patient was treated with SYNTHROID (88 A?g, Qd) (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6937630-9 | Retinal Pigment Epithelial Tear
on Aug 10, 2010 Male patient from SWITZERLAND , weighting 125.7 lb, was treated with Lucentis (View Usage). Patient had the following side effects: retinal pigment epithelial tear. Lucentis dosage: 0.05 Ml, Qd. During the same period patient was treated with VISUDYNE (Unk) (View Visudyne Review and Visudyne Label ), HARNAL (View Harnal Review and Harnal Label ).

6937416-5 | Arrhythmia, Atrial Fibrillation
on Aug 09, 2010 Female patient from SWITZERLAND , weighting 189.6 lb, was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?). Lucentis dosage: Unk. Patient was hospitalized.

6930966-7 | Eye Haemorrhage, Injection Site Pain, Musculoskeletal Discomfort, Visual Acuity Reduced
Patient was taking Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: eye haemorrhage, injection site pain, musculoskeletal discomfort, visual acuity reduced on Aug 06, 2010 from SWITZERLAND Additional patient health information: Female patient , 85 years of age, weighting 121.3 lb, . Lucentis dosage: Unk. During the same period patient was treated with SYMBICORT (View Symbicort Review and Symbicort Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), BRICANYL INHALER (View Bricanyl Inhaler Review and Bricanyl Inhaler Label ).

6930598-0 | Aortic Stenosis, Coronary Artery Disease, Myocardial Infarction
Adverse event was reported on Aug 05, 2010 by a Male patient taking Lucentis (View Usage) (Dosage: ) . Location: SWITZERLAND , 91 years of age, Patient had the following side effects: aortic stenosis, coronary artery disease (What is coronary artery disease?), myocardial infarction. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FRUMIL (View Frumil Review and Frumil Label ). Patient was hospitalized.

6925624-9 | Retinal Pigment Epithelial Tear
on Aug 02, 2010 Female patient from SWITZERLAND , 59 years of age, was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: retinal pigment epithelial tear. Lucentis dosage: Unk.

6923990-1 | Retinal Pigment Epithelial Tear
on Aug 02, 2010 Male patient from SWITZERLAND , 77 years of age, was diagnosed with maculopathy and was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: retinal pigment epithelial tear. Lucentis dosage: Unk.

6919509-1 | Eye Infection, Eye Inflammation, Eye Pain, Lacrimation Increased
Patient was taking Lucentis (View Usage). Patient had the following side effects: eye infection (What is eye infection?), eye inflammation, eye pain, lacrimation increased on Jul 29, 2010 from SWITZERLAND Additional patient health information: Male patient , 59 years of age, . Lucentis dosage: Unk.

6918071-7 | Confusional State, Gait Disturbance, Haemorrhagic Stroke, Headache, Hypertension, International Normalised Ratio Increased
Adverse event was reported on Jul 28, 2010 by a Male patient taking Lucentis (View Usage) (Dosage: Unk) was diagnosed with arrhythmia (What is arrhythmia?), hypertension and. Location: FRANCE , weighting 158.7 lb, After Lucentis was administered, patient had the following side effects: confusional state, gait disturbance, haemorrhagic stroke, headache (What is headache?), hypertension, international normalised ratio increased. During the same period patient was treated with PREVISCAN (Unk) (View Previscan Review and Previscan Label ), STABLON (Unk) (View Stablon Review and Stablon Label ), ANTIHYPERTENSIVES (Unk) (View Antihypertensives Review and Antihypertensives Label ), FLUINDIONE (Unk) (View Fluindione Review and Fluindione Label ), VALSARTAN (View Valsartan Review and Valsartan Label ). Patient was hospitalized and became disabled.

6917889-4 | Cerebral Haemorrhage
on Jul 28, 2010 Male patient from SWITZERLAND , 84 years of age, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage. Lucentis dosage: . During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), FLUINDIONE (Unk) (View Fluindione Review and Fluindione Label ).

6917143-0 | Transient Ischaemic Attack
on Jul 27, 2010 Female patient from SWITZERLAND , 86 years of age, was treated with Lucentis (View Usage). Patient had the following side effects: transient ischaemic attack. Lucentis dosage: 0.5 Mg, Unk. During the same period patient was treated with BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ).

6912337-2 | Cataract Operation
Patient was taking Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: cataract operation on Aug 02, 2010 from SWITZERLAND Additional patient health information: Female patient , 73 years of age, weighting 127.9 lb, . Lucentis dosage: 5 Unk, Unk. During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ). Patient was hospitalized.

6907217-2 | Acute Respiratory Failure, Cardiac Failure Acute
Adverse event was reported on Jul 23, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: Unk) . Location: SWITZERLAND , 85 years of age, Patient experienced the following unwanted or unexpected effects: acute respiratory failure, cardiac failure acute. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), VENTOLIN (View Ventolin Review and Ventolin Label ).

6906639-3 | Herpes Zoster, Memory Impairment
on Jul 22, 2010 Female patient from SWITZERLAND , weighting 143.3 lb, was treated with Lucentis (View Usage). Patient had the following side effects: herpes zoster, memory impairment. Lucentis dosage: 1 Amp, Qd.

6905934-1 | Endophthalmitis, Retinal Neovascularisation
on Jul 22, 2010 Female patient from SWITZERLAND , 61 years of age, was diagnosed with retinal vein occlusion, macular oedema and was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: endophthalmitis, retinal neovascularisation. Lucentis dosage: .

6905931-6 | Retinal Pigment Epithelial Tear
Patient was taking Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: retinal pigment epithelial tear on Jul 22, 2010 from SWITZERLAND Additional patient health information: Female patient , 75 years of age, . Lucentis dosage: .

6901084-9 | Myocardial Infarction, Pulmonary Embolism
Adverse event was reported on Jul 20, 2010 by a Male patient taking Lucentis (View Usage) (Dosage: Unk) . Location: SWITZERLAND , 81 years of age, Patient had the following side effects: myocardial infarction, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ).

6896337-7 | Arrhythmia
on Jul 19, 2010 Female patient from SWITZERLAND , weighting 189.6 lb, was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: arrhythmia (What is arrhythmia?). Lucentis dosage: Unk. Patient was hospitalized.

6888373-1 | Retinal Detachment
on Jul 16, 2010 Female patient from SWITZERLAND , 82 years of age, weighting 149.9 lb, was diagnosed with retinal detachment and was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: retinal detachment. Lucentis dosage: . During the same period patient was treated with CINNARIZINE (Unk) (View Cinnarizine Review and Cinnarizine Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), DIMETICONE (Unk) (View Dimeticone Review and Dimeticone Label ), MULTIVITAMIN (Unk) (View Multivitamin Review and Multivitamin Label ).

6887851-9 | Metastatic Neoplasm
Patient was taking Lucentis (View Usage). Patient had the following side effects: metastatic neoplasm on Jul 16, 2010 from SWITZERLAND Additional patient health information: Female patient , 73 years of age, . Lucentis dosage: 5 Mg, Unk.